LIVOSTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Livostin, and what generic alternatives are available?
Livostin is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in LIVOSTIN is levocabastine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levocabastine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIVOSTIN?
- What are the global sales for LIVOSTIN?
- What is Average Wholesale Price for LIVOSTIN?
Summary for LIVOSTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 622 |
DailyMed Link: | LIVOSTIN at DailyMed |
US Patents and Regulatory Information for LIVOSTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | LIVOSTIN | levocabastine hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 020219-001 | Nov 10, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIVOSTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LIVOSTIN | levocabastine hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 020219-001 | Nov 10, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIVOSTIN
See the table below for patents covering LIVOSTIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 157738 | ⤷ Sign Up | |
Denmark | 192984 | ⤷ Sign Up | |
Croatia | P930475 | PROCESS FOR THE PREPARATION OF NOVEL 1-(CYCLOHEXYL)-4-ARYL-4-PIPERIDINECARBOXYLIC ACID DERIVATIVES | ⤷ Sign Up |
Ireland | 810125 | ⤷ Sign Up | |
Japan | H0622718 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LIVOSTIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0034415 | 93C0014 | Belgium | ⤷ Sign Up | PRODUCT NAME: LEVOCABASTINE HYDROCHLORIDE; NAT. REG.: 2S 400 F 11 19910604; FIRST REG.: DK 8252 19910111 |
0034415 | SPC/GB95/006 | United Kingdom | ⤷ Sign Up | SPC/GB95/006, EXPIRES: 20060110 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |